REDWOOD CITY, CA, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company”), an innovative Technology-as-a-Service (TaaS) company committed to transforming chronic condition detection and management wit…
Biotricity to Announce Continued Growth in Fiscal 2026 Third Quarter Financial Results and Business Update Call on February 11th
Company continues to drive Revenue Growth, Margin Strength, Operational Efficiency, and continued positive EBITDA REDWOOD CITY, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), an innovative Technology-as-a-Service (…
The Zacks Analyst Blog Highlights Hims & Hers Health, Biotricity and Privia Health
For Immediate Release Chicago, IL – December 24, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial…
3 Healthcare IT Stocks Up More Than 20% in 2025 With More Room to Run
Healthcare information technology (IT) continues to garner substantial investor attention in 2025 as digital transformation in the U.S. health system accelerates. Providers and payers are investing in technology that supports telehealth ac…
Purpose Investments Inc. Announces 2025 Estimated Annual Income and Capital Gains Distributions
TORONTO, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Purpose Investments Inc. (“Purpose”) today announced the estimated annual distributions of income and capital gains for its open-end exchange-traded funds and closed-end funds (the “Funds”) for th…
Biotricity Inc. (BTCY) Reports Q2 Loss, Lags Revenue Estimates
Biotricity Inc. (BTCY) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to a loss of $0.07 per share a year ago. These figures are adjusted for non-recurring items. Thi…
Biotricity Inc. (BTCY) Reports Q2 Loss, Lags Revenue Estimates
Biotricity Inc. (BTCY) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to a loss of $0.07 per share a year ago. These figures are adjusted for non-recurring items. Thi…
Fate Therapeutics (FATE) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to a loss of $0.4 per share a year ago. These figures are adjusted for non-recurring items. Th…
Biotricity to Host Fiscal 2026 Second Quarter Financial Results and Business Update Call on November 14th
REDWOOD CITY, CA, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company”), an innovative Technology-as-a-Service (TaaS) company committed to redefining the landscape of the healthcare industry with st…
Doximity (DOCS) Tops Q2 Earnings and Revenue Estimates
Doximity (DOCS) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.3 per share a year ago. These figures are adjusted for non-recurring items. This…
iRhythm Technologies (IRTC) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to a loss of $1.26 per share a year ago. These figures are adjusted for non-recurring items…
Biotricity and B-Secur Target the Consumer Wearables Market with Expansion of Next-Gen Cardiac Monitoring Platform
REDWOOD CITY, Calif./BELFAST, Northern Ireland, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), an innovative medical technology company specializing in remote cardiac monitoring solutions, and B-Secur, a leader in ECG alg…
Purpose Investments Inc. Announces August 2025 Distributions
Purpose Investments Inc. TORONTO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Purpose Investments Inc. (“Purpose”) is pleased to announce distributions for the month of August 2025 for its open-end exchange-traded funds and closed-end funds (“the Fu…
Biotricity Reinforces Growth Trajectory, Kicking Off Fiscal 2026 with Strong First Quarter Results Featuring Revenue Growth, Positive EBITDA and Improved Margins
REDWOOD CITY, CA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company”), an innovative Technology-as-a-Service (TaaS) company committed to redefining the landscape of the healthcare industry with st…
Biotricity to Host Fiscal 2026 First Quarter Financial Results and Business Update Call on August 14th
Company to announce continued Revenue Growth, Improvements in Margins, Operational Efficiency, and a shift to positive EBITDA REDWOOD CITY, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), an innovative Technology-as…
Are Medical Stocks Lagging Cardinal Health (CAH) This Year?
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Cardinal Health (CAH) is a stock that can certainly grab the attention of many investors, but do its recent returns compare…
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
DALLAS, July 17, 2023 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small and mid-sized commercial-stage companies, today provided a corporate…
Third Quarter 2022 Financial Results to be Announced in Early November DALLAS, Oct. 18, 2022 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to sma…
Fourth Quarter 2021 Financial Results to be Announced in March DALLAS, Feb. 9, 2022 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and m…
BioRestorative Therapies Announces Nomination of Two New Members to the Board of Directors
MELVILLE, N.Y., Oct. 26, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced the nomination of two new indep…
Gainers Phunware, Inc. (NASDAQ: PHUN) shares jumped 471.2% to close at $8.74 on Friday. Phunware shares jumped over 45% on Thursday, possibly in sympathy with Digital World Acquisition as traders circulated an article from May 2020 highlig…
Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) shares climbed 356.8% to close at $45.50 on Thursday following an announcement the company will merge with Trump Media & Technology Group. Portillo's Inc. (NASDAQ: PTLO) rose 45.5% to…
Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) shares jumped 132.3% to $23.14 following an announcement the company will merge with Trump Media & Technology Group. Portillo's Inc. (NASDAQ: PTLO) gained 45.9% to $29.18 after the com…
Biotricity Launches Biocare Cardiac Application for Samsung's Galaxy Watch4 Series
REDWOOD CITY, CA / ACCESSWIRE / October 7, 2021 / Biotricity Inc. (NASDAQ: BTCY), a medical diagnostic and consumer healthcare technology company, today announced the upcoming release of Biocare Cardiac - a personal, cardiac health applica…
Gainers Camber Energy, Inc.. (NYSE: CEI) shares surged 95.9% to close at $1.78 on Thursday after dipping over 40% on Wednesday. Camber Energy filed amended 8K showing financial statements of Viking. Merus N.V. (NASDAQ: MRUS) jumped 37.5% t…
Gainers Camber Energy, Inc.. (NYSE: CEI) jumped 44.2% to $1.3102 after dipping over 40% on Wednesday. Camber Energy filed amended 8K showing financial statements of Viking. Paltalk, Inc. (NASDAQ: PALT) shares jumped 40.1% to $9.71 after dr…
Biotricity CEO Discusses Calculated Growth Strategy in Audio Interview with SmallCapVoice.com
AUSTIN, Texas, March 16, 2021 (GLOBE NEWSWIRE) -- SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Dr. Waqaas Al-Siddiq, CEO of Biotricity Inc. (OTCQB: BTCY) (“the Company”), a modern medical technology com…
Biotricity Completes $9.5M of Convertible Promissory Notes to Institutional and Retail Investors
REDWOOD CITY, Calif., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it has completed a series of closings pursuant to which it sold an…
Biotricity Announces New Solution for Personal Heart Management with Bioheart
Bioheart comfortably and continuously monitors daily activities and provides advanced heart performance data in a user-friendly format LAS VEGAS, Jan. 11, 2021 (GLOBE NEWSWIRE) -- CES – Biotricity Inc. (OTCQB:BTCY), a medical diagnostic an…
Biotricity Submitted 510(k) U.S. FDA Filing for Biotres
REDWOOD CITY, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it made a 510(k) submission to the U.S. Food and Drug Administratio…
Biotricity to Present at the 13th Annual LD Micro Main Event and Host Virtual One-on-One Meetings with Investors
REDWOOD CITY, Calif., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that CEO Waqaas Al-Siddiq and CFO John Ayanoglou are scheduled to prese…
REDWOOD CITY, Calif., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it has completed required lab testing and is completing its 510(k)…
Biotricity Reports Results for the Quarter Ended September 30, 2020
Revenues grow 64.8% over the immediately preceding quarter and a 115.3% increase over the corresponding period of the prior yearLoss per share of 8.5 cents in line with levels of immediately preceding quarter REDWOOD CITY, Calif., Nov. 17,…